Patient-centered reports help reduce worry and improve understanding of test results

Using language that minimizes adverse events in studies presented at oncology conferences could compromise patient care. (Journal of Cancer Policy) While care for patients with

Struc­ture Ther­a­peu­tics is throw­ing its oral GLP-1 in­to the weight loss ring with promis­ing — al­beit ear­ly and small — da­ta from a Phase Ib

Sen. Raphael Warnock (D-GA) and eight oth­er Geor­gia law­mak­ers on Thurs­day asked the FDA for more trans­paren­cy over the short­age of can­cer drugs like cis­platin